反复呼吸道感染患儿应用脾多肽治疗的临床疗效观察

Clinical Efficacy in Children With Recurrent Respiratory Tract Infection in Treatment of Spleen Polypeptide

目的分析反复呼吸道感染患儿应用脾多肽治疗的临床疗效。方法回顾分析2012年12月~2014年12月本院89例反复呼吸道感染患儿临床资料,按不同治疗方案分为两组,对照组43例行常规治疗,研究组46例在其基础上行脾多肽治疗,观察两组疗效。结果对照组总有效率76.7%低于研究组95.7%,且各症状改善时间均多于研究组,差异均具统计学意义（P〈0.05）。结论反复呼吸道感染患儿应用脾多肽治疗的临床疗效显著。

Objective Analysis of the clinical efficacy of recurrent respiratory tract infection in children application spleen polypeptide therapy. Methods Review December 2012-2014 in our hospital 89 cases of clinical data in children with recurrent respiratory tract infections, according to the different treatment options are divided into two groups, 43 routine routine treatment group of 46 patients in their study based on the uplink spleen polypeptide treatment were observed efficacy. Results The control group, the total efficiency of 76.7% was significantly lower than the study group was 95.7%, and each time symptoms are more than the study group, the differences were statistically significant（P〈0.05）. Conclusion Clinical efficacy in children with recurrent respiratory tract infections spleen polypeptide therapeutic applications significantly.